{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:32:17Z","timestamp":1793140337637,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.eclinm.2026.104144","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:35:56Z","timestamp":1786440956000},"page":"104144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hepatitis A vaccination and its public-health impact in routine prevention and outbreak control: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"99","author":[{"given":"Jana","family":"Malinov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-1736","authenticated-orcid":false,"given":"Marek","family":"Petr\u00e1\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3178-1577","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"S\u00fdkora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Dlouh\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Rosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9053-4123","authenticated-orcid":false,"given":"Ivana Kr\u00e1lov\u00e1","family":"Lesn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104144_bib1","series-title":"Hepatitis A","year":"2025"},{"key":"10.1016\/j.eclinm.2026.104144_bib2","series-title":"Chapter 9: Hepatitis A","author":"Foster","year":"2024"},{"key":"10.1016\/j.eclinm.2026.104144_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cld.2018.01.005","article-title":"Viral hepatitis and acute liver failure","volume":"22","author":"Sedhom","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.eclinm.2026.104144_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031716","article-title":"Globalization and the changing epidemiology of hepatitis A virus","volume":"8","author":"Jacobsen","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.eclinm.2026.104144_bib5","first-page":"493","article-title":"Hepatitis A vaccines: WHO position paper, October 2022","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.eclinm.2026.104144_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cmi.2025.11.026","article-title":"Achieving global immunity against hepatitis A through universal vaccination: a position paper from the European Society of Clinical Microbiology and Infectious Diseases Study Group for Viral Hepatitis","volume":"32","author":"S\u0103ndulescu","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eclinm.2026.104144_bib7","series-title":"Plotkin's Vaccines","first-page":"365","article-title":"Chapter 26 \u2013 hepatitis A vaccines","author":"Averhoff","year":"2023"},{"key":"10.1016\/j.eclinm.2026.104144_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/INF.0000000000000042","article-title":"Impact of the single-dose immunization strategy against hepatitis A in Argentina","volume":"33","author":"Vizzotti","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eclinm.2026.104144_bib9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa070546","article-title":"Hepatitis A vaccine versus immune globulin for postexposure prophylaxis","volume":"357","author":"Victor","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.104144_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.eclinm.2026.104144_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2026.104144_bib12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104144_bib13","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.104144_bib14","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2026.104144_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014Grade evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2026.104144_bib16","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.eclinm.2026.104144_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/eb-2014-101967","article-title":"A hands-on practical tutorial on performing meta-analysis with stata","volume":"17","author":"Chaimani","year":"2014","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.eclinm.2026.104144_bib18","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/0264-410X(92)90573-3","article-title":"Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile","volume":"10","author":"Riedemann","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199208133270702","article-title":"A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children","volume":"327","author":"Werzberger","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.104144_bib20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1994.03510410040030","article-title":"Protection against hepatitis A by an inactivated vaccine","volume":"271","author":"Innis","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104144_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1096-9071(199602)48:2<147::AID-JMV5>3.0.CO;2-9","article-title":"Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children","volume":"48","author":"Richtmann","year":"1996","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2026.104144_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.11569\/wcjd.v11.i6.693","article-title":"Long-term immunogenicity and protective efficacy of a live attenuated hepatitis A vaccine (LA-1 strain)","volume":"11","author":"Gong","year":"2003","journal-title":"WCJD"},{"key":"10.1016\/j.eclinm.2026.104144_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1086\/377309","article-title":"Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial","volume":"188","author":"P\u00e9rez","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2026.104144_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0264-410X(96)00304-0","article-title":"Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans","volume":"15","author":"Mao","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v6.i6.829","article-title":"H2 strain attenuated live hepatitis A vaccines: protective efficacy in a hepatitis A outbreak","volume":"6","author":"Zhao","year":"2000","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.eclinm.2026.104144_bib26","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1001\/jama.286.23.2968","article-title":"Control of hepatitis A through routine vaccination of children","volume":"286","author":"Averhoff","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104144_bib27","first-page":"678","article-title":"[Immunogenicity and efficacy of two live attenuated hepatitis A vaccines (H(2) strains and LA-1 strains)]","volume":"82","author":"Xu","year":"2002","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.eclinm.2026.104144_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2893.2008.01031.x","article-title":"Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up","volume":"15","author":"Fisenka","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.eclinm.2026.104144_bib29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/infdis\/jiw411","article-title":"Single-dose hepatitis A immunization: 7.5-year observational pilot study in Nicaraguan children to assess protective effectiveness and humoral immune memory response","volume":"214","author":"Mayorga","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2026.104144_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.29780","article-title":"Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus\u2013positive individuals during the outbreak of acute hepatitis A","volume":"68","author":"Lin","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.eclinm.2026.104144_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jvh.13249","article-title":"Effectiveness of single-dose administration of inactivated hepatitis A virus vaccination in the Republic of Korea armed forces, 2013-2016","volume":"27","author":"Im","year":"2020","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.eclinm.2026.104144_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jmv.1890440427","article-title":"Interruption of an outbreak of hepatitis A in two villages by vaccination","volume":"44","author":"Pr\u00edkazsk\u00fd","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2026.104144_bib33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archpedi.1996.02170320079014","article-title":"A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine","volume":"150","author":"McMahon","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.eclinm.2026.104144_bib34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(98)08139-2","article-title":"Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial","volume":"353","author":"Sagliocca","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2026.104144_bib35","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.vaccine.2007.11.016","article-title":"Hepatitis A vaccination effectiveness during an outbreak in the Ukraine","volume":"26","author":"Selnikova","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib36","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3748\/wjg.14.2771","article-title":"Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community","volume":"14","author":"Shen","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.eclinm.2026.104144_bib37","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.vaccine.2014.07.048","article-title":"Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines","volume":"32","author":"Freeman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/21645515.2017.1264798","article-title":"Effectiveness of hepatitis A vaccination as post-exposure prophylaxis","volume":"13","author":"Parr\u00f3n","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eclinm.2026.104144_bib39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ebiom.2018.11.023","article-title":"Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: implications for immunization policies","volume":"39","author":"Sabri\u00e0","year":"2019","journal-title":"eBioMedicine"},{"key":"10.1016\/j.eclinm.2026.104144_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of hepatitis A in Israel following universal immunization of toddlers","volume":"294","author":"Dagan","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104144_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2893.2008.01029.x","article-title":"Incidence of hepatitis A in Argentina after vaccination","volume":"15","author":"Vacchino","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.eclinm.2026.104144_bib42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.vaccine.2018.12.054","article-title":"Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil","volume":"37","author":"Souto","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/1560-7917.ES2015.20.7.21040","article-title":"The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012","volume":"20","author":"Levine","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eclinm.2026.104144_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13052-025-01996-8","article-title":"Comparison of safety and immunogenicity between Healive\u00ae, Havrix\u00ae and live attenuated Hepatitis A vaccines in pediatric population: a systematic review with meta-analysis","volume":"51","author":"Abo Zeid","year":"2025","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.eclinm.2026.104144_bib45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vaccine.2005.07.102","article-title":"Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical Bayesian meta-analysis","volume":"24","author":"Shire","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1586\/14760584.2016.1150182","article-title":"Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review","volume":"15","author":"Bakker","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eclinm.2026.104144_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vaccine.2012.04.104","article-title":"Long-term protective effects of hepatitis A vaccines. A systematic review","volume":"31","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib48","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0264-410X(03)00135-X","article-title":"The effectiveness and safety of hepatitis A vaccine: a systematic review","volume":"21","author":"Demicheli","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2026.104144_bib49","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/21645515.2016.1242539","article-title":"Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines \u2013 a systematic review","volume":"13","author":"Stuurman","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eclinm.2026.104144_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.vaccine.2021.01.038","article-title":"One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: a systematic review","volume":"40","author":"Andani","year":"2022","journal-title":"Vaccine"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:33:06Z","timestamp":1793136786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S2589537026003974"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104144","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis A vaccination and its public-health impact in routine prevention and outbreak control: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104144"}}